| 000 | 01160 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516212747.0 | ||
| 264 | 0 | _c20140922 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2014.107 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTomayko, J F | |
| 245 | 0 | 0 |
_aThe challenge of antimicrobial resistance: new regulatory tools to support product development. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cAug 2014 |
||
| 300 |
_a166-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xtrends |
| 650 | 0 | 4 |
_aDrug Discovery _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aRex, J H | |
| 700 | 1 | _aTenero, D M | |
| 700 | 1 | _aGoldberger, M | |
| 700 | 1 | _aEisenstein, B I | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 96 _gno. 2 _gp. 166-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2014.107 _zAvailable from publisher's website |
| 999 |
_c23821621 _d23821621 |
||